Manufacturing, Gene Therapies

Sartorius and Teknova Team Up for Gene Therapy Process Development

March 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Catalent Expands UpTempo AAV Platform

March 09, 2023

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.

Advances in In Vivo CAR T-cell Therapies

March 01, 2023

Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.

AbbVie and Capsida Strike $674 Million Gene Therapy Development Deal

February 24, 2023

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

The Center for Breakthrough Medicines Announces Plasmid Manufacturing Service

February 07, 2023

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

Emmes Launches Cell and Gene Therapy Center

December 14, 2022

Emmes’ new facility is designed to support clients conducting cell and gene therapy research worldwide.

CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies

October 28, 2022

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

AAPS 2022 Conference Highlights

October 25, 2022

Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Com, discuss cell & gene therapies and co-processed APIs respectively.

Addressing Developmental Challenges of Gene Therapy Viral Vectors

October 16, 2022

Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.

FDA Expands Oversight of Cell and Gene Therapies

October 12, 2022

CBER maps modernization plan to handle surge in research and applications.